New drug combo aims to fight advanced bladder cancer
NCT ID NCT07261592
First seen Jan 07, 2026 · Last updated May 13, 2026 · Updated 20 times
Summary
This study tests a drug called entinostat combined with standard chemotherapy for people with advanced bladder cancer that has gotten worse after initial treatment. The goal is to see if this combination can shrink tumors or slow the disease. About 29 adults with measurable tumors and good organ function will take part. This is an early-phase trial, so the main focus is safety and effectiveness, not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Nanjing, Jiangsu, 210008, China
Conditions
Explore the condition pages connected to this study.